ZBTB47

Across TCGA pan-cancer cohorts, ZBTB47 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZBTB47 data layer compared with 27 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher ZBTB47 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZBTB47 expression acts as an unfavorable survival marker.

CESC, OV, and UCEC are the cancer types where ZBTB47 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Median	II,III,IV	0.166	0.765	<.001	48	view →
OV	OS	Median	II,III,IV	0.023	0.844	<.001	36	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ZBTB47–CESC (OS)

Open the CESC breakdown →